Xiaolei Wei

Department of Hematology, Southern Medical University

Affiliated withSouthern Medical University

Research Area

Biography

Xiaolei Wei has not added Biography.
If you are Xiaolei Wei and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2026

Other Publications

Article	Year
Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma. Leukemia research\| PubMed ID: 24713260	2014
The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression. Journal of hematology & oncology\| PubMed ID: 24739401	2014
Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma\| PubMed ID: 25175043	2015
The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma. PloS one\| PubMed ID: 25974110	2015
[Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 26913389	2016
Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP. International journal of hematology\| PubMed ID: 27393279	2016
The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP. Scientific reports\| PubMed ID: 29051524	2017
Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget\| PubMed ID: 29100345	2017
Biology of Tumor Associated Macrophages in Diffuse Large B Cell Lymphoma. DNA and cell biology\| PubMed ID: 30403536	2018
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 30862694	2019
Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP. Scientific reports\| PubMed ID: 31053761	2019
Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma. International journal of hematology\| PubMed ID: 31993938	2020
CD8GITR T cells may negatively regulate T cell overactivation in aplastic anemia. Immunological investigations\| PubMed ID: 32462957	2021
Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma. Frontiers in oncology\| PubMed ID: 33585232	2020
LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p. Cancer management and research\| PubMed ID: 33958893	2021
Partial immunoparesis contributes to risk of early infections in patients with multiple myeloma. Translational cancer research\| PubMed ID: 35116375	2021
CD43 is an adverse prognostic factor in newly diagnosed multiple myeloma. Leukemia & lymphoma\| PubMed ID: 35819872	2022
Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow Grafts. Transplantation and cellular therapy\| PubMed ID: 36049734	2022
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation\| PubMed ID: 36528754	2023
Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments. Annals of hematology\| PubMed ID: 36949293	2023
Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study. BMJ open\| PubMed ID: 38159939	2023
Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma. Aging\| PubMed ID: 38240686	2024
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8 T cell function. Cellular oncology (Dordrecht, Netherlands)\| PubMed ID: 38809326	2024
Metabolic tumor volume from baseline [18 F]FDG PET/CT at diagnosis improves the IPI stratification in patients with diffuse large B-cell lymphoma. Annals of hematology\| PubMed ID: 39222121	2024
NUF2 overexpression predicts poor outcomes in multiple myeloma. Genes & diseases\| PubMed ID: 39524538	2025
Single-Cell Multiomics Reveals TCR Clonotype-Specific Phenotype and Stemness Heterogeneity of T-ALL Cells. Cell proliferation\| PubMed ID: 39675761	2025
Mutations in AMBRA1 aggravate β-thalassemia by impairing autophagy-mediated clearance of free α-globin. Blood\| PubMed ID: 39693613	2025
A novel prognostic model utilizing TMTV and SUVmax from F-FDG PET/CT for predicting overall survival in patients with extranodal NK/T- cell lymphoma. BMC cancer\| PubMed ID: 40033269	2025
A common TBP-binding site mutation elevates γ-globin levels by competitive globin switching change in β-thalassemia. Blood advances\| PubMed ID: 40197981	2025
Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study. Cancer communications (London, England)\| PubMed ID: 40344323	2025
Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivot... Journal of translational medicine\| PubMed ID: 40426201	2025
Enhancing plasmacytoid dendritic cell functionality with retinoic acid for improved multiple myeloma therapy. Molecular therapy. Oncology\| PubMed ID: 40502919	2025
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance. Science immunology\| PubMed ID: 40512837	2025
Real-world data on clinical outcomes and validation of prognostic models for angioimmunoblastic T-cell lymphoma: a multicentric retrospective study in Southern China. Frontiers in oncology\| PubMed ID: 40556671	2025
Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study. Discover oncology\| PubMed ID: 40601115	2025
Low peripheral blood B lymphocyte count predicts poor outcome in patients with multiple myeloma. Immunobiology\| PubMed ID: 40639196	2025
Potential therapeutic GSK-3β inhibitor 9-ING-41 is active in combination with venetoclax in double-hit lymphoma (DHL). Cancer biology & therapy\| PubMed ID: 41220107	2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort study. Molecular biomedicine\| PubMed ID: 41364305	2025
The effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study. BMC cancer\| PubMed ID: 41430153	2025